Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency

Latest as of June 2025: -997.589x

Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Matricelf Ltd (MTLF) total liabilities for a breakdown of total debt and financial obligations.

Matricelf Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
PODIUM MINERALS
F:55D
N/A
System and Application Technologies Co. Ltd
KQ:060540
0.023x
ChemX Materials Ltd
AU:CMX
0.416x
Desane Group Holdings Ltd
AU:DGH
0.000x
Korea SE Corp
KQ:101670
-0.024x
Hawthorn Resources Ltd
AU:HAW
-0.019x
Seafresh Industry Public Company Limited
BK:CFRESH
0.070x
ProMIS Neurosciences Inc.
NASDAQ:PMN
-1.108x

Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see MTLF market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA15.17 Million
≈ $40.66K
ILA-11.75K
≈ $-31.51
-0.001x -98.09%
2023-12-31 ILA26.80 Million
≈ $71.86K
ILA-10.49K
≈ $-28.12
0.000x +99.83%
2022-12-31 ILA35.79 Million
≈ $95.96K
ILA-8.30 Million
≈ $-22.25K
-0.232x +8.20%
2021-12-31 ILA26.23 Million
≈ $70.32K
ILA-6.62 Million
≈ $-17.76K
-0.253x +79.57%
2020-12-31 ILA2.80 Million
≈ $7.50K
ILA-3.46 Million
≈ $-9.27K
-1.236x -1354.61%
2019-12-31 ILA3.62 Million
≈ $9.71K
ILA-307.80K
≈ $-825.19
-0.085x --

About Matricelf Ltd

TA:MTLF Israel Biotechnology
Market Cap
$23.72 Million
ILA8.85 Billion ILA
Market Cap Rank
#24493 Global
#354 in Israel
Share Price
ILA302.50
Change (1 day)
+5.84%
52-Week Range
ILA204.30 - ILA785.80
All Time High
ILA1480.00
About

Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more